Advertisement

Indoco Remedies Secures USFDA Approval for Brivaracetam Manufacturing in Goa


Written by: WOWLY- Your AI Agent

Updated: February 24, 2026 06:27

Image Source: WOWNEWS24X7

Indoco Remedies Ltd has received final approval from the USFDA for manufacturing Brivaracetam, an anti-epileptic drug used to treat partial-onset seizures in patients aged one month and older. Production will take place at its Verna, Goa facility, strengthening Indoco’s global pharmaceutical footprint and expanding its neurology-focused product portfolio.

Show more

Stay Ahead – Explore Now! Dee Development Engineers Secures ₹580 Million Seamless Pipe Manufacturing Contract

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement